Anthrax toxin: receptor binding, internalization, pore formation, and translocation
- PMID: 17335404
- DOI: 10.1146/annurev.biochem.75.103004.142728
Anthrax toxin: receptor binding, internalization, pore formation, and translocation
Abstract
Anthrax toxin consists of three nontoxic proteins that self-assemble at the surface of receptor-bearing mammalian cells or in solution, yielding a series of toxic complexes. Two of the proteins, called Lethal Factor (LF) and Edema Factor (EF), are enzymes that act on cytosolic substrates. The third, termed Protective Antigen (PA), is a multifunctional protein that binds to receptors, orchestrates the assembly and internalization of the complexes, and delivers them to the endosome. There, the PA moiety forms a pore in the endosomal membrane and promotes translocation of LF and EF to the cytosol. Recent advances in understanding the entry process include insights into how PA recognizes its two known receptors and its ligands, LF and EF; how the PA:receptor interaction influences the pH-dependence of pore formation; and how the pore functions in promoting translocation of LF and EF across the endosomal membrane.
Similar articles
-
Crystal structure of a complex between anthrax toxin and its host cell receptor.Nature. 2004 Aug 19;430(7002):905-8. doi: 10.1038/nature02763. Epub 2004 Jul 4. Nature. 2004. PMID: 15243628
-
Receptor palmitoylation and ubiquitination regulate anthrax toxin endocytosis.J Cell Biol. 2006 Jan 16;172(2):309-20. doi: 10.1083/jcb.200507067. Epub 2006 Jan 9. J Cell Biol. 2006. PMID: 16401723 Free PMC article.
-
Anthrax toxin receptor drives protective antigen oligomerization and stabilizes the heptameric and octameric oligomer by a similar mechanism.PLoS One. 2010 Nov 8;5(11):e13888. doi: 10.1371/journal.pone.0013888. PLoS One. 2010. PMID: 21079738 Free PMC article.
-
Membrane translocation by anthrax toxin.Mol Aspects Med. 2009 Dec;30(6):413-22. doi: 10.1016/j.mam.2009.06.003. Epub 2009 Jun 27. Mol Aspects Med. 2009. PMID: 19563824 Free PMC article. Review.
-
Anthrax toxin.Annu Rev Cell Dev Biol. 2003;19:45-70. doi: 10.1146/annurev.cellbio.19.111301.140655. Annu Rev Cell Dev Biol. 2003. PMID: 14570563 Review.
Cited by
-
Vaccine protection against Bacillus cereus-mediated respiratory anthrax-like disease in mice.Infect Immun. 2013 Mar;81(3):1008-17. doi: 10.1128/IAI.01346-12. Epub 2013 Jan 14. Infect Immun. 2013. PMID: 23319564 Free PMC article.
-
Interaction of the Clostridium difficile Binary Toxin CDT and Its Host Cell Receptor, Lipolysis-stimulated Lipoprotein Receptor (LSR).J Biol Chem. 2015 May 29;290(22):14031-44. doi: 10.1074/jbc.M115.650523. Epub 2015 Apr 16. J Biol Chem. 2015. PMID: 25882847 Free PMC article.
-
Both lethal and edema toxins of Bacillus anthracis disrupt the human dendritic cell chemokine network.PLoS One. 2012;7(8):e43266. doi: 10.1371/journal.pone.0043266. Epub 2012 Aug 24. PLoS One. 2012. PMID: 22937027 Free PMC article.
-
Functional characterization of an extended binding component of the actin-ADP-ribosylating C2 toxin detected in Clostridium botulinum strain (C) 2300.Infect Immun. 2010 Apr;78(4):1468-74. doi: 10.1128/IAI.01351-09. Epub 2010 Feb 9. Infect Immun. 2010. PMID: 20145093 Free PMC article.
-
Treatment of ovarian cancer with modified anthrax toxin.Proc Natl Acad Sci U S A. 2022 Aug 9;119(32):e2210179119. doi: 10.1073/pnas.2210179119. Epub 2022 Aug 2. Proc Natl Acad Sci U S A. 2022. PMID: 35917343 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources